{"id":"W4408563004","doi":"10.1016/j.esmoop.2025.104506","title":"Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Merck; Pfizer","keywords":"Javelin; Urothelial carcinoma; Avelumab; Medicine; Oncology; Carcinoma; Term (time); Urology; Internal medicine; Bladder cancer; Immunotherapy; Cancer; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001963359,0.0003168473,0.0006494729,0.00007479985,0.0001750531,0.00008012434,0.00056318,0.0001337088,0.0005462045],"category_scores_gemma":[0.0002715369,0.0001859532,0.0001989897,0.000207665,0.00007334236,0.0001608364,0.0002512764,0.0002212858,0.00004351019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002256882,"about_ca_system_score_gemma":0.0003554957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003691847,"about_ca_topic_score_gemma":0.004269718,"domain_scores_codex":[0.9981326,0.00006689424,0.0005431834,0.0005767265,0.0002493862,0.0004311704],"domain_scores_gemma":[0.9986605,0.000340491,0.0001248978,0.0006502614,0.0001362239,0.00008762358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04949845,0.001619465,0.9043285,0.00004997134,0.0003956485,0.00003175595,0.0007435931,0.000008389957,0.000006733916,0.00008259099,0.007915895,0.03531903],"study_design_scores_gemma":[0.2004629,0.000590755,0.7925533,0.000221473,0.0002114842,6.328448e-7,0.00004990665,0.00002694444,0.0003641584,0.0003400763,0.00499624,0.0001821497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9753013,0.00019087,0.000577331,0.007664442,0.001762072,0.01096766,0.0004986158,0.00003833462,0.002999379],"genre_scores_gemma":[0.9835594,0.00005552323,0.00040626,0.003867253,0.0002519193,0.00149588,0.0003115412,0.00004628242,0.01000593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1509644,"threshold_uncertainty_score":0.7582951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03674774194139571,"score_gpt":0.3389780122487699,"score_spread":0.3022302703073743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}